US 8778980
Heterocyclic aspartyl protease inhibitors
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8778980 (Heterocyclic aspartyl protease inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P31/10, A61P31/18